18Sep
Government Continues to Closely Scrutinize Pharmaceutical Marketing Practices
On September 4, 2019 the Department of Justice (DOJ) announced a $15.4 million settlement with pharmaceutical company Mallinckrodt ARD LLC (Mallinckrodt) to resolve alleged violations of the Anti-Kickback Statute (AKS) in two whistleblower suits...
By:
Robinson+Cole Health Law Diagnosis
Related
The #MeToo movement did not begin in 2017, but its viral spread as a social media campaign began at ...
Read More >
Since the introduction by the Capital Market Authority (the “CMA”) of the Kingdom of Saudi Arabia ...
Read More >
California’s Supreme Court has cut off an area of significant potential exposure for California emp...
Read More >
Whether you are the owner or the general contractor, dealing with mechanic’s liens filed by subcont...
Read More >
Assembly Bill (AB) 5, currently pending in the California legislature, would impose the “ABC” test...
Read More >
Congress is poised to overturn two recent judicial interpretations of the whistleblower protections ...
Read More >